MedTrace Logo

An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care.

NCT07552805 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 490

Last updated 2026-08-13

No results posted yet for this study

Summary

The SENSE-ECO study is a prospective, randomized trial of 490 high-risk patients designed to show that the MultiSense® remote monitoring patch safely reduces hospital stays following major digestive surgery. By continuously tracking vital signs for five days at home, the device aims to maintain clinical safety and quality of life while decreasing overall healthcare costs for the French medical system.

Conditions

  • Reduction in the Initial Length of Stay

Interventions

DEVICE

Monitoring by MultiSense®

The MultiSense device will be placed on the patient's back and will allow physicians to remotely monitor six biological parameters

Sponsors & Collaborators

  • Calypse

    collaborator UNKNOWN

  • BPIfrance

    collaborator OTHER

  • Rhythm Diagnostic Systems

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-16
Primary Completion
2027-10-17
Completion
2027-12-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07552805 on ClinicalTrials.gov